Corinne Bonnet | Academic Influence

Corinne Bonnet's AcademicInfluence.com Rankings

Corinne Bonnet

History

#3971

World Rank

#5535

Historical Rank

history Degrees

Download Badge

History

Corinne Bonnet's Degrees

PhD History Université catholique de Louvain

Why Is Corinne Bonnet Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Corinne Bonnet is Professor of Greek History at the University of Toulouse, France. She is known for her work on ancient Mediterranean history and religion. She is currently the Principal Investigator of the ERC Advanced Grant project Mapping Ancient Polytheisms.

(See a Problem?)

Corinne Bonnet's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial (2011) (314)
CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. (2007) (228)
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. (2016) (221)
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers (2017) (93)
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL). (2016) (86)
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features (2013) (62)
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study. (2019) (51)
Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients (2017) (47)
Expression of Growth Factors and Their Receptors in the Postnatal Rat Cochlea (1998) (43)
Assessing the potential toxicity of resuspended sediment (2000) (41)
Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen (2006) (41)
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. (2012) (40)
Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA. (2020) (33)
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B). (2013) (29)
Darbepoetin‐alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial (2013) (29)
Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study (2002) (28)
Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial. (2014) (27)
No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study. (2005) (27)
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older. (2021) (23)
Use of immunofluorescence technique for studying a nitrobacter population from wastewater treatment plant following discharge in river sediments : First experimental data (1997) (22)
Darbepoetin-Alfa and I.V. Iron Administration after Autologous Hematopoietic Stem Cell Transplantation: A Prospective Randomized Multicenter Trial (2008) (21)
Limited usefulness of CA125 measurement in the management of Hodgkin's and non‐Hodgkin's lymphoma (2007) (20)
Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study (2007) (19)
Imagine No Religion. How Modern Abstractions Hide Ancient Realities (2018) (17)
A Prospective Randomized Study Comparing Dose Intensive Immunochemotherapy with R-ACVBP vs Standard R-CHOP In Younger Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study LNH03-2B (2010) (16)
Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies (2016) (16)
Antipatros l'Ascalonite dévoré par un lion : Commentaire de CIS I, 115 (1990) (15)
Unmet needs in the scientific approach to older patients with lymphoma (2017) (14)
Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study (2018) (14)
Panthée : religious transformations in the Graeco-Roman Empire (2013) (13)
Long‐term safety follow‐up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation (2015) (12)
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. (2006) (11)
PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup (2017) (11)
Intensifi ed chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diff use large B-cell lymphoma ( LNH 032 B ) : an open-label randomised phase 3 trial (2011) (10)
[Mantle cell lymphoma]. (2010) (9)
Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study (2014) (9)
Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly (2014) (8)
Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial (2009) (8)
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA. (2021) (8)
Obinutuzumab Versus Rituximab in Combination with ACVBP-14 or CHOP-14 Following a PET-Driven Strategy in Aa-IPI 1-3 DLBCL Patients (< 60 years): Third Planned Interim and Final Analyses of the Gained Trial (2017) (8)
On Gods and Earth : The Tophet and the Construction of a New identity in Punic Carthage (2011) (8)
BHS Guidelines for the treatment of Burkitt’s lymphoma (2015) (8)
Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long‐term survival (2015) (7)
Distinction of Lymphoma from Sarcoidosis on 18F-FDG PET/CT: Evaluation of Radiomics-Feature–Guided Machine Learning Versus Human Reader Performance (2022) (7)
Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. (2013) (6)
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL (2021) (6)
Brad E. Kelle, Frank Ritchel Ames (éd.), Writing and Reading War. Rhetoric, Gender, and ethics in Biblical and Modern Contexts (2009) (6)
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial (2022) (5)
Thesaurus cultus et rituum antiquorum (ThesCRA) (2007) (5)
Positron Emission Tomography–Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study (2022) (5)
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome (2022) (5)
A Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma (2016) (5)
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations (2022) (5)
Outcomes after first-line immunochemotherapy for primary mediastinal B cell lymphoma patients: a LYSA study. (2021) (5)
BHS guidelines for the treatment of marginal zone lymphomas (2014) (5)
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. (2012) (5)
A PHASE II LYSA STUDY OF OBINUTUZUMAB COMBINED WITH LENALIDOMIDE FOR RELAPSED OR REFRACTORY FOLLICULAR B‐CELL LYMPHOMA (2017) (5)
Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Older Patients with Advanced-Stage Classical Hodgkin Lymphoma: Results of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA) (2019) (4)
A First Report on [18F]FPRGD2 PET/CT Imaging in Multiple Myeloma (2017) (4)
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years (2021) (4)
In Vitro Ototoxicity of aminoglycosides and platin derivatives. A semi-automatic assay for sensory hair cell damage in explanted rat organ of corti. (1998) (4)
IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY (2017) (4)
Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL (2013) (4)
R-CHOP14 As a Standard of Care in Primary Mediastinal B Cell Lymphoma: A 10-YEARS Experience of Lysa Centers (2020) (3)
Mapping ancient gods: naming and embodiment beyond “anthropomorphism”. A survey of the field in echo to the books of M.S. Smith and R. Parker (2019) (3)
Greeks and Phoenicians in the Western Mediterranean (2014) (3)
The Religious Life in Hellenistic Phoenicia: ‘Middle Ground’ and New Agencies (2013) (3)
Dual‐tracer PET/CT scan after injection of combined [18F]NaF and [18F]FDG outperforms MRI in the detection of myeloma lesions (2019) (3)
Israël Finkelstein, Amihai Mazar, The Quest for the Historical Israel. Debating Archaeology and the History of Early Israel. Invited Lectures Delivered at the Sixth Biennial Colloquium of the International Institute for Secular Humanistic Judaism, Detroit, October 2005 (2009) (3)
Suzanne L. Marchand, German Orientalism in the Age of Empire. Religion, Race, and Scholarship (2013) (3)
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma ( LNH 03-1 B ) (2013) (3)
Results from the Belgian mantle cell lymphoma registry (2017) (2)
Ibrutinib in Association with R-DHAP/Ox for Patients with Relapsed/Refractory B-Cell Lymphoma: Preliminary Results of the Biblos Phase Ib Lysa Study (2016) (2)
Phoenician identities in Hellenistic times: strategies and negotiations (2014) (2)
Ibrutinib in association with R-DHAP/ox for patients with relapsed/refractory b-cell lymphoma: Results of the escalating phase of the BIBLOS phase Ib LYSA study. (2018) (2)
BHS guidelines for primary central nervous system lymphoma (2016) (2)
Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial. (2005) (2)
Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study (2021) (2)
Expression of growth factors and their receptors in various compartments of the postnatal cochlea. (1997) (2)
Comparison of combined whole-body [18F]NaF and [18F]FDG PET/CT versus MRI for the detection of myeloma lesions (2016) (2)
Outcomes after ﬁ rst-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study (2021) (2)
BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias (2016) (2)
Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The French Lymphoma Study Association (LYSA) Registry Data (2018) (2)
Guidelines of the Belgian hamatological Society for newly diagnosed and relapsed follicular lymphoma 2012. (2012) (2)
Waldenström’s macroglobulinaemia : Belgian Hematology Society guidelines (2015) (1)
A phase 3 study to evaluate the efficacy and safety of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL). (2021) (1)
BHS guidelines for the treatment of newly diagnosed diffuse large B-cell lymphoma ( DLBCL ) anno 2020 (2020) (1)
inMIND: A phase 3 study of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab for relapsed/refractory follicular or marginal zone lymphoma. (2022) (1)
Molecular cloning of mouse AstaC, a brain protein which is upregulated during development. (1996) (1)
Effect of neuropeptides on cultured postnatal auditory neurons. (1997) (1)
Diffuse Large B-Cell Lymphomas of the Waldeyer’s Ring Frequently Have a Germinal Center-Like Phenotype: A Clinico-Pathological Study of 209 Patients from the Groupe d’Etude des Lymphomes de L’Adulte (GELA). (2007) (1)
Infections after Allogeneic Hematopoietic Stem Cell Transplantation with a Nonmyeloablative Conditioning Regimen. (2004) (1)
[Current management of marginal zone lymphomas]. (2015) (1)
[Diffuse large B cell lymphoma: management in 2012]. (2012) (1)
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study. (2022) (1)
Updated BHS guidelines for the treatment of chronic lymphocytic leukaemia , mantle cell lymphoma and Waldenström macroglobulinemia anno 2018 (2018) (1)
IMPACT OF DUSP22 REARRANGEMENT ON THE PROGNOSIS OF SYSTEMIC ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A LYSA AND TENOMIC STUDY (2021) (1)
Correlation between RNA and protein levels in a large european series from the LYSA (2013) (1)
MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT (2021) (1)
[Current therapies in hematology]. (2007) (1)
The Hellenistic Period and Hellenization in Phoenicia (2019) (1)
Kristopher F. B. Fletcher et Osman Umurhan (éds.), Classical Antiquity in Heavy Metal Music (2020) (1)
Narrating the past and the future : the position of the religions orientales and the mystères païens in the evolutionary histories of religion of Franz Cumont and Alfred Loisy (2018) (1)
‚Orient’ since Franz Cumont: Enrichment and Dearth of a Concept. (2009) (1)
Giorgos Papantoniou, Christine E. Morris, Athanasios K. Vionis (eds), Unlocking Sacred Landscapes: Spatial Analysis of Ritual and Cult in the Mediterranean (2020) (1)
IBCL-131: inMIND: A Phase 3 Study of Tafasitamab + Lenalidomide Add-On to Rituximab vs Placebo + Lenalidomide Add-On to Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL) (2021) (0)
Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset (2015) (0)
[Monoclonal antibodies in hematology in 2009]. (2009) (0)
Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency (2015) (0)
Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society (2014) (0)
A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation. (2009) (0)
P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL) (2022) (0)
Final Analysis of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA) Using Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Patients over 60 Years with Advanced-Stage Classical Hodgkin Lymphoma (2021) (0)
Limited usefulness of CA 125 measurement in the management of patients with hodgkin's or non-hodgkin's lymphoma. (2006) (0)
BRENTUXIMAB VEDOTIN AS CONSOLIDATION TREATMENT IN PATIENTS WITH STAGE I/II CLASSICAL HODGKIN'S LYMPHOMA AND A POSITIVE FDG‐PET AFTER 2 CYCLES OF ABVD: A LYSA PHASE 2 STUDY (2021) (0)
Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data (2019) (0)
[Current treatment of follicular lymphoma]. (2009) (0)
[Mantle cell lymphoma: management in 2011]. (2011) (0)
Loren T. Stuckenbruck, Stephen C. Barton, Benjamin G. Wold, (éd.), Memory in the Bible and Antiquity (2008) (0)
How can we determine the role of radiotherapy in the treatment of localized aggressive non Hodgkin's lymphoma? (2007) (0)
Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial" (2022) (0)
Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation (2014) (0)
Albert I. Baumgarten, Elias Bickerman as a Historian of the Jews. A Twentieth Century Tale (2011) (0)
L'Apollodore de James George Frazer (2009) (0)
Gary Schneider, The Culture of Epistolarity. Vernacular Letters and Letter Writing in Early Modern England, 1500-1700 (2006) (0)
Cytogenetic and molecular testing in lymphoma patients Part 2 : Aberrations in aggressive B-cell lymphomas , Hodgkin lymphoma , and T and NK lymphomas PRACTICE GUIDELINES (2018) (0)
Glen W. Bowersock, From Gibbon to Auden. Essays on the Classical Tradition (2010) (0)
Mise en perspective épistolaire. « Denn ich denke oft im Stillen an Sie. » Hermann Diels et Franz Cumont : la filiation intellectuelle à l’épreuve de la guerre 14-18 (2009) (0)
Diffuse large B-cell lymphoma (DLBCL) of the waldeyer'ring (WR) frequently have a GC-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). (2008) (0)
CD30 expression in peripheral T-cell lymphomas, not otherwise specified: is it relevant for the identification of distinct subgroups?(LYS011) (2012) (0)
Jaime Alvar: Romanising Oriental Gods. Myth, Salvation and Ethics in the Cults of Cybele, Isis and Mithras. Translator and editor: Richard Gordon. (2011) (0)
Carol Poster, Linda C. Mitchell (éd.), Letter-Writing Manuals and Instruction from Antiquity to the Present. Historical and Bibliographic Studies (2008) (0)
Michael D. Konaris, The Greek Gods in Modern Sc (2018) (0)
Book review: Comparer en histoire des religions. Controverses et propositions, written by Calame, C., Lincoln, B. (2014) (0)
Mitchell, S., Van Nuffelen, P. (eds.) 2010. One God. Pagan Monotheism in the Roman Empire. Cambridge, Cambridge University Press. x, 239 pp. Pr. £55.00 (hb). ISBN 9780521194167. (2012) (0)
Royal Prophecy in the Old Testament and in the Ancient Near East: some methodological observations and exemples (2002) (0)
Franz Cumont, Mikhail Rostovtzeff and Dura Europos (2010) (0)
Highlights of the 13th International Conference on Malignant Lymphoma (2015) (0)
L'onomastique de Melqart. En appendice : l'inscription punique CIS I, 4612 (1989) (0)
[Diffuse large B-cell lymphoma: a revolutionary treatment based on genetically-modified immune cells called CAR T cells]. (2021) (0)
Faut-il repenser l'Antiquité, entre Orient et Occident?: au sujet de Jack Goodoy, "The Theft of History", Cambridge, University Press, 2006 (2008) (0)
Breast Implant Associated-Anaplastic Large-Cell Lymphoma (BIA-ALCL): Data Based on the Lymphoma Study Association (LYSA) Registry. Promising Results of Brentuximab Vedotin Combined with Cyclophosphamide, Doxorubicin and Prednisone (BV-CHP) As First Line Treatment for Patient Requiring Chemotherapy (2021) (0)
No advantage of chemoradiotherapy over chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: results of the LNH93-4 GELA study. (2005) (0)
Alaisdar A. Macdonald, Michael W. Rwomey, Gerrit J. Reinink, Learned Antiquity. Scholarship and Society in the Near East, the Greco-Roman World and the Early Medieval West (2006) (0)
[Current management of myelodysplastic syndromes]. (2011) (0)
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA. (2022) (0)
Julius Beloch et la question phénicienne (2019) (0)
R.G. Kratz ; H. Spieckermann (eds.), Divine Wrath and Divine Mercy in the World of Antiquity, Tübingen 2008 (2008) (0)
Simultaneous diagnosis of CLL and CML in a single patient with evidence for two different cell clones (2013) (0)
Jean-Marie Husser, Introduction à l’histoire des religions (2020) (0)
The Jerusalem temple between “theology” and archaeology: which issues, what dialogue? (2017) (0)
Joseph Geiger, Hellenism in the East. Studies on Greek Intellectuals in Palestine (2017) (0)
ROLE OF UP‐FRONT AUTOLOGOUS STEM CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMAS: a PROPENSITY SCORE MATCHING ANALYSIS OF PATIENTS FROM LYSA CENTERS (2017) (0)
Narrating the past and the future: The position of the religions orientales and the mystères païens in the evolutionistic (2013) (0)
Ancient religions and the 'religion de l'humanite' in the early 20th-century history of religions : the dialogue between Loisy and Cumont (2017) (0)
Cytogenetic and molecular testing in lymphoma patients (2018) (0)
ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B ‐ CELL LYMPHOMA (AAIPI = 0) : RESULTS OF THE PHASE 3 LYSA LNH 1B TRIAL (2021) (0)
P. J. Rus, Mette Moltesen et Pia Guldager, Catalogue of Ancient Sculptures. I. Aegean, Cypriote, and Graeco-Phoenician (1991) (0)
Index of Papyrological Sources (2013) (0)
Individualisation as an historical trend in the religion of the Phoenician cities in the Hellenistic times? (2009) (0)
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group (2022) (0)
Index of Epigraphic Sources (2013) (0)
Mario Liverani, Imagining Babylon: The Modern S (2019) (0)
Hematologic recovery after autologus stem cell transplantation in multiple myeloma: a single center experience of 225 patients (2016) (0)
INMIND: A PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA (2021) (0)
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]. (2021) (0)
Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation. (2014) (0)
Abstract 4921: Population pharmacokinetic modeling of ibrutinib administered in patients with relapsed or refractory B cell malignancies eligible for autologous stem cell transplantation (2018) (0)
ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial (2014) (0)

This paper list is powered by the following services:

Other Resources About Corinne Bonnet

en.wikipedia.org

What Schools Are Affiliated With Corinne Bonnet?

Corinne Bonnet is affiliated with the following schools:

Image Attributions

Image Source for Corinne Bonnet